Research Notes: Scientific evidence connecting Tysabri to Progressive Multifocal Leukoencephalopathy

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Detailed topic guide

Understanding Scientific evidence connecting Tysabri to Progressive Multifocal Leukoencephalopathy

In-depth context and analysis on this topic for researchers and advocates.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.